Skip to main content
. 2023 May 15;80(7):673–681. doi: 10.1001/jamaneurol.2023.1168

Table 2. Parkinson Disease (PD) and Other Neurodegenerative Parkinsonism Diagnoses.

Variable No. (%) P value
Camp Lejeune (n = 279) Camp Pendleton (n = 151) Total (n = 430)
VHA records (% total PD) 263 (94.3) 135 (89.4) 398 (92.6) .07
Medicare only (% total PD) 16 (5.7) 16 (10.6) 32 (7.4)
Crude PD prevalence, % 0.33 0.21 0.27 <.001
Probable PD (% total PD) 249 (89.2) 127 (84.1) 376 (87.4) .12
Possible PD (% total PD) 30 (10.8) 24 (15.9) 54 (12.6)
PD diagnosis age, mean (SD); range, y 54.7 (7.2); 30.0-75.0 53.2 (7.7); 29.0-70.0 54.2 (7.4); 29.0-75.0 .04
Years from start of camp residence until PD diagnosis, mean (SD); range 33.9 (7.1); 4.5-45.0 32.2 (7.3); 10.5-44.7 33.3 (7.2); 4.5-45.0 .02
PD before January 13, 2017 148 (53.0) 109 (72.2) 257 (59.7) .19
PD with VHA usage before PD incidence date 173 (62.0) 87 (57.6) 260 (60.5) <.001
Other neurodegenerative parkinsonism
DLB 12 (0.014) 7 (0.010) 19 (0.012) .41
MSA 4 (0.005) 10 (0.014) 14 (0.009) .11
PSP 5 (0.006) 5 (0.007) 10 (0.006) .82
CBD 1 (0.001) 1 (0.001) 2 (0.001) .92
Indeterminate 7 (0.008) 5 (0.007) 12 (0.008) .74

Abbreviations: CBD, corticobasal degeneration; DLB, dementia with Lewy bodies; MSA, multiple system atrophy; PSP, progressive supranuclear palsy; VHA, Veterans Health Administration.